Pap tests in women aged 21-29 and 30 – 65 years of age In average risk women, annual cervical cytology screening has been shown to offer no advantage over screening performed at 3-year intervals, without HPV co-testing, for age 21-29 or 5-year intervals, with HPV co-testing, for age 30-65. However, a well-woman visit should occur annually to discuss prevention practices, recognizing risk factors for disease, identifying medical problems, and establishing the clinician–patient relationship. Women who hav...